Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference54 articles.
1. Validating survivin as a cancer therapeutic target;Altieri;Nat. Rev. Cancer,2003
2. The case for survivin as a regulator or microtubule dynamics and cell-death decisions;Altieri;Curr. Opin. Cell Biol.,2006
3. Survivin, cancer networks and pathway-directed drug discovery;Altieri;Nat. Rev. Cancer,2008
4. Regulation of survivin expression through Bcr-Abl/MAPK cascade: targeting survivin overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells;Carter;Blood,2006
5. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells;Carvalho;J. Cell Sci.,2003
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prodigiosin Inhibits Transforming Growth FactorβSignaling by Interfering Receptor Recycling and Subcellular Translocation in Epithelial Cells;Molecular Pharmacology;2024-01-26
2. Research progress, challenges, and perspectives in microbial pigment production for industrial applications - A review;Dyes and Pigments;2023-02
3. Rise of the natural red pigment ‘prodigiosin’ as an immunomodulator in cancer;Cancer Cell International;2022-12-28
4. Prodigiosin-Functionalized Probiotic Ghosts as a Bioinspired Combination Against Colorectal Cancer Cells;Probiotics and Antimicrobial Proteins;2022-08-28
5. Bacteria as a treasure house of secondary metabolites with anticancer potential;Seminars in Cancer Biology;2021-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3